Skip to main content

Market Access Monitor

Service of monitoring key reimbursement and HTA developments for medical devices, in-vitro diagnostic tests, and digital technologies in Europe and globally

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Pocket Brief: EU Prioritization Matrix for Hospital Medical Devices

MTRC is pleased to present the 2025 EU Prioritization Matrix for Hospital Medical Devices - your annual, refresh-and-reuse guide to strategic market entry across Europe.

Our EU Prioritization Matrix provides an immediate strategic advantage by categorizing markets into high, moderate, and low-priority tiers from a Market Access perspective. It is specifically calibrated for hospital-based technologies, excluding day-case procedures and IVDs, to ensure precise relevance.

Drawn from years of frontline consulting engagements, this matrix offers a definitive framework for strategic planning and resource allocation. Our rankings are based on proven hurdles and pathways, helping you plan investments and allocate resources with maximum efficiency.

Pin, share, and keep it on hand - your annual shortcut to smarter market access planning.

Request the Pocket Brief and gain the clarity needed to confidently prioritize markets for a successful European entry.